132 related articles for article (PubMed ID: 10517352)
1. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
[TBL] [Abstract][Full Text] [Related]
2. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
5. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine.
Nakano K; Yasaka T; Schram KH; Reimer ML; McClure TD; Nakao T; Yamamoto H
J Chromatogr; 1990 Aug; 515():537-46. PubMed ID: 2283377
[TBL] [Abstract][Full Text] [Related]
6. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
Nakano K; Shindo K; Yasaka T; Yamamoto H
J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
[TBL] [Abstract][Full Text] [Related]
8. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
9. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
10. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
[TBL] [Abstract][Full Text] [Related]
11. [Development of high performance liquid chromatographic method using monolithic column for the determination of urinary nucleosides].
Zhao X; Zheng Y; Zhang P; Kong H; Xu G
Se Pu; 2005 Jan; 23(1):73-5. PubMed ID: 15881371
[TBL] [Abstract][Full Text] [Related]
12. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
[TBL] [Abstract][Full Text] [Related]
13. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
Seidel A; Seidel P; Manuwald O; Herbarth O
Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
[TBL] [Abstract][Full Text] [Related]
14. Modified nucleosides in body fluids of tumor-bearing patients.
Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
[TBL] [Abstract][Full Text] [Related]
15. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
16. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
[TBL] [Abstract][Full Text] [Related]
17. Patterns of urinary excretion of modified nucleosides.
Gehrke CW; Kuo KC; Waalkes TP; Borek E
Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
[TBL] [Abstract][Full Text] [Related]
18. Urinary nucleosides.
Schram KH
Mass Spectrom Rev; 1998; 17(3):131-251. PubMed ID: 10095827
[TBL] [Abstract][Full Text] [Related]
19. Analysis of normal and modified nucleosides in urine samples by high-performance liquid chromatography with different stationary phases.
Studzińska S; Buszewski B
Biomed Chromatogr; 2014 Aug; 28(8):1140-6. PubMed ID: 24453057
[TBL] [Abstract][Full Text] [Related]
20. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
Struck-Lewicka W; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
